UBS AM
ELV icon

UBS AM’s Elevance Health ELV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.16B Buy
2,979,321
+303,118
+11% +$118M 0.23% 91
2025
Q1
$1.16B Buy
2,676,203
+324,040
+14% +$141M 0.3% 67
2024
Q4
$868M Buy
2,352,163
+199,550
+9% +$73.6M 0.2% 87
2024
Q3
$1.12B Buy
2,152,613
+31,740
+1% +$16.5M 0.29% 65
2024
Q2
$1.15B Buy
2,120,873
+451,811
+27% +$245M 0.33% 56
2024
Q1
$865M Sell
1,669,062
-38,282
-2% -$19.9M 0.31% 61
2023
Q4
$805M Buy
1,707,344
+21,589
+1% +$10.2M 0.32% 56
2023
Q3
$734M Buy
1,685,755
+87,358
+5% +$38M 0.33% 56
2023
Q2
$735M Hold
1,598,397
0.36% 54
2023
Q1
$735M Sell
1,598,397
-29,541
-2% -$13.6M 0.36% 54
2022
Q4
$835M Buy
1,627,938
+39,803
+3% +$20.4M 0.44% 40
2022
Q3
$721M Sell
1,588,135
-81,418
-5% -$37M 0.4% 43
2022
Q2
$806M Buy
1,669,553
+569,965
+52% +$275M 0.42% 42
2022
Q1
$540M Sell
1,099,588
-28,198
-3% -$13.9M 0.23% 85
2021
Q4
$523M Sell
1,127,786
-604,898
-35% -$280M 0.2% 109
2021
Q3
$646M Buy
1,732,684
+588,390
+51% +$219M 0.27% 73
2021
Q2
$437M Sell
1,144,294
-105,260
-8% -$40.2M 0.19% 116
2021
Q1
$449M Sell
1,249,554
-437,957
-26% -$157M 0.2% 104
2020
Q4
$542M Sell
1,687,511
-57,969
-3% -$18.6M 0.25% 79
2020
Q3
$469M Buy
1,745,480
+64,685
+4% +$17.4M 0.25% 79
2020
Q2
$442M Buy
1,680,795
+38,164
+2% +$10M 0.27% 75
2020
Q1
$373M Sell
1,642,631
-179,187
-10% -$40.7M 0.27% 73
2019
Q4
$550M Sell
1,821,818
-262,570
-13% -$79.3M 0.34% 57
2019
Q3
$500M Buy
2,084,388
+208,760
+11% +$50.1M 0.34% 56
2019
Q2
$529M Sell
1,875,628
-113,008
-6% -$31.9M 0.38% 51
2019
Q1
$571M Buy
1,988,636
+42,586
+2% +$12.2M 0.42% 44
2018
Q4
$511M Sell
1,946,050
-45,609
-2% -$12M 0.44% 42
2018
Q3
$546M Sell
1,991,659
-169,260
-8% -$46.4M 0.41% 44
2018
Q2
$514M Buy
2,160,919
+305,636
+16% +$72.8M 0.39% 43
2018
Q1
$408M Sell
1,855,283
-75,887
-4% -$16.7M 0.32% 64
2017
Q4
$435M Buy
1,931,170
+200,330
+12% +$45.1M 0.37% 53
2017
Q3
$329M Buy
1,730,840
+147,079
+9% +$27.9M 0.3% 66
2017
Q2
$298M Buy
1,583,761
+706,775
+81% +$133M 0.29% 72
2017
Q1
$145M Buy
876,986
+68,942
+9% +$11.4M 0.15% 156
2016
Q4
$116M Sell
808,044
-95,170
-11% -$13.7M 0.13% 177
2016
Q3
$113M Buy
903,214
+42,771
+5% +$5.36M 0.12% 184
2016
Q2
$113M Buy
860,443
+1,327
+0.2% +$174K 0.13% 180
2016
Q1
$119M Sell
859,116
-92,170
-10% -$12.8M 0.14% 162
2015
Q4
$133M Sell
951,286
-698,925
-42% -$97.5M 0.15% 159
2015
Q3
$231M Sell
1,650,211
-110,480
-6% -$15.5M 0.25% 81
2015
Q2
$289M Buy
1,760,691
+26,320
+2% +$4.32M 0.28% 81
2015
Q1
$268M Buy
1,734,371
+256,903
+17% +$39.7M 0.26% 87
2014
Q4
$186M Buy
1,477,468
+77,146
+6% +$9.69M 0.18% 132
2014
Q3
$168M Buy
1,400,322
+49,143
+4% +$5.88M 0.17% 139
2014
Q2
$145M Sell
1,351,179
-30,233
-2% -$3.25M 0.15% 158
2014
Q1
$138M Buy
1,381,412
+131,788
+11% +$13.1M 0.15% 165
2013
Q4
$115M Buy
1,249,624
+253
+0% +$23.4K 0.13% 185
2013
Q3
$104M Buy
1,249,371
+8,437
+0.7% +$705K 0.13% 186
2013
Q2
$102M Buy
+1,240,934
New +$102M 0.13% 182